Basal Cell Carcinoma (BCC) Terminated Phase 1 Trials for Doxorubicin (DB00997)

Also known as: BCC - Basal Cell Carcinoma / Basal Cell Carcinomas / Basal Cell Carcinoma / Carcinoma basal cell / Basalioma / Basal cell epithelioma / Rodent ulcer / Basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma of skin (disorder) / Carcinoma, Basal Cell

DBCOND0040396 (Basal Cell Carcinoma (BCC))Terminated1 IdentifierTitlePurposeDrugs
NCT03646188Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)Treatment